UNASSIGNED: Objectives. In this study, we assessed the extra-articular symptoms in constellation with selected serum cytokines and disease activity in @entity1691 ( @entity1691 ). @entity1 and Methods. We studied 287 @entity1691 @entity1 : 131 had @entity5427 , 110 had PsA, and 46 had SAPHO. We assessed extra-articular symptoms in all cases. In 191 @entity1691 @entity1 , we measured serum @entity650 ( @entity650 ), @entity8923 ( @entity8923 ), @entity21264 ( @entity21264 ), @entity2232 ( @entity2232 ), @entity7 ( @entity7 ), and @entity4179 (EGF). Results. @entity1 with @entity6990 ( @entity6990 ) had higher VAS (P = 0.0008), BADSDAI (P = 0.0001), ASDAS-ESR (P = 0.04), CRP (P = 0.006), @entity650 (P = 0.02), and @entity8923 (P = 0.03) levels. @entity1 with @entity29 ( @entity29 ) had higher VAS (P = 0.03), CRP (P = 0.0009), and @entity650 (P = 0.0003) levels. @entity1 with @entity272 had lower VAS (P = 0.001) and BASDAI (P = 0.00007) levels. @entity1 with @entity5144 had lower VAS (P = 0.006), BASDAI (P = 0.00001), and CRP (P = 0.02) and higher @entity21264 (P = 0.04) levels. @entity1 with @entity6223 had lower BASDAI (P = 0.04) and higher @entity2232 (P = 0.001) levels. Conclusions. @entity1691 @entity1 with increased serum @entity8923 and decreased serum @entity2232 had an increased risk of extra-articular symptoms. In @entity1691 @entity1 , increased disease activity was associated with an increased risk of @entity6990 and @entity29 and a decreased risk of @entity272 , @entity5144 , and @entity6223 .

Extra-Articular Symptoms in Constellation with Selected Serum Cytokines and Disease Activity in XXXX .

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients'] @entity650 :: ('3569', 'Gene') :: ['IL-6', 'interleukin-6'] @entity5427 :: ('MESH:D017204', 'Disease') :: ['AS'] @entity6990 :: ('MESH:D014606', 'Disease') :: ['acute anterior uveitis', 'AAU'] @entity2232 :: ('1906', 'Gene') :: ['endothelin-1', 'ET-1'] @entity7 :: ('7422', 'Gene') :: ['vascular endothelial growth factor', 'VEGF'] @entity6223 :: ('MESH:D010520', 'Disease') :: ['PPP'] @entity29 :: ('MESH:D015212', 'Disease') :: ['IBD', 'inflammatory bowel disease'] @entity5144 :: ('MESH:D015535', 'Disease') :: ['psoriatic onycholysis'] @entity1691 :: ('MESH:D013167', 'Disease') :: ['spondyloarthritis', 'SpA'] @entity8923 :: ('3606', 'Gene') :: ['IL-18', 'interleukin-18'] @entity4179 :: ('1950', 'Gene') :: ['epidermal growth factor'] @entity21264 :: ('27178', 'Gene') :: ['interleukin-23', 'IL-23'] @entity272 :: ('MESH:D012871', 'Disease') :: ['skin psoriasis']
@entity1691 :: (MESH:D013167,Disease) :: ['Spondyloarthritis']
